Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Executive or director change
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Executive or director change
  5. S-3ASR Offering Registration Statement
  6. 3 Insider Initial Statement of Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Material agreement
  10. 4 Open-market sale Director sold 6,686 shares at an average $31.17 ($208,397)
  11. 8-K Event Executive or director change
  12. 4 Open-market sale Director sold 6,686 shares at an average $27.96 ($186,908)
  13. 8-K Event Shareholder vote results
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 6,686 shares at $25.04 ($167,389)
  19. 4 Open-market sale President and CEO sold 8,400 shares at $24.00 ($201,600)
  20. 4 Derivatives Options or other derivatives

Page 28 of 37 · 725 filings